National Vaccine and Serum Institute: GEN2-Recombinant COVID-19 Vaccine (CHO Cells)

Vaccine Type: Protein Subunit

Vaccine Trial & Approval Tracker

This vaccine has reached Phase 1 trials.

About Trial Phases

Phase 1: 1 Trial

Phase 2: 0 Trials

There are no trials for this phase.

Phase 3: 0 Trials

There are no trials for this phase.

Approvals

This vaccine is not yet approved.

Registered Trials